Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Davide Mariotti

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Frontiers in Molecular Biosciences|December 13, 2021
Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 InfectionGiulia Matusali, Flavia Trionfetti, Veronica Bordoni, et al.
Emerging Microbes & Infections|February 20, 2026
Mapping transcriptional patterns of MPXV in human epithelial cellsLudovica Picarone, Daniele Pietrucci, Davide Mariotti, et al.
International Journal of Molecular Sciences|May 7, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster VaccineAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Cell Death Discovery|January 6, 2026
Tetrandrine-driven autophagy suppresses SARS-CoV-2 replication by modulating cholesterol and IGF signaling pathwaysLais de O Marchioro, Sofia De Stefanis, Beatriz G Araújo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 5, 2024
Dielectric Barrier Plasma Discharge Exsolution of Nanoparticles at Room Temperature and Atmospheric PressureAtta Ul Haq, Fiorenza Fanelli, Leonidas Bekris, et al.
Scientific Reports|August 10, 2020
Thyroid cancer diagnosis by Raman spectroscopyMarco Sbroscia, Michael Di Gioacchino, Paolo Ascenzi, et al.
Vaccines|May 7, 2025
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive TherapiesMario Ferraioli, Alessandra Aiello, Immacolata Prevete, et al.
Advanced Healthcare Materials|June 17, 2026
Atomic Layer Deposition Processes: Versatile Platforms for Engineering ZnO-Chitosan BiointerfacesMabel Moreno, Anjana Devi, David Zanders, et al.
Scientific Reports|April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Vaccines|December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIVAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Frontiers in Molecular Biosciences|December 13, 2021
Pleural Mesothelial Cells Modulate the Inflammatory/Profibrotic Response During SARS-CoV-2 InfectionGiulia Matusali, Flavia Trionfetti, Veronica Bordoni, et al.
Emerging Microbes & Infections|February 20, 2026
Mapping transcriptional patterns of MPXV in human epithelial cellsLudovica Picarone, Daniele Pietrucci, Davide Mariotti, et al.
International Journal of Molecular Sciences|May 7, 2025
Immune Response Against Recent Omicron Sub-Lineages in Persons with HIV Receiving a Protein-Based or mRNA XBB.1.5 SARS-CoV-2 Booster VaccineAlessandra Vergori, Giulia Matusali, Eleonora Cimini, et al.
Cell Death Discovery|January 6, 2026
Tetrandrine-driven autophagy suppresses SARS-CoV-2 replication by modulating cholesterol and IGF signaling pathwaysLais de O Marchioro, Sofia De Stefanis, Beatriz G Araújo, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|July 5, 2024
Dielectric Barrier Plasma Discharge Exsolution of Nanoparticles at Room Temperature and Atmospheric PressureAtta Ul Haq, Fiorenza Fanelli, Leonidas Bekris, et al.
Scientific Reports|August 10, 2020
Thyroid cancer diagnosis by Raman spectroscopyMarco Sbroscia, Michael Di Gioacchino, Paolo Ascenzi, et al.
Vaccines|May 7, 2025
Anti-SARS-CoV-2 B and T-Cell Immune Responses Persist 12 Months After mRNA Vaccination with BNT162b2 in Systemic Lupus Erythematosus Patients Independently of Immunosuppressive TherapiesMario Ferraioli, Alessandra Aiello, Immacolata Prevete, et al.
Advanced Healthcare Materials|June 17, 2026
Atomic Layer Deposition Processes: Versatile Platforms for Engineering ZnO-Chitosan BiointerfacesMabel Moreno, Anjana Devi, David Zanders, et al.
Scientific Reports|April 24, 2022
Persistent Spike-specific T cell immunity despite antibody reduction after 3 months from SARS-CoV-2 BNT162b2-mRNA vaccineChiara Agrati, Concetta Castilletti, Delia Goletti, et al.
Vaccines|December 23, 2023
Long Term Assessment of Anti-SARS-CoV-2 Immunogenicity after mRNA Vaccine in Persons Living with HIVAlessandra Vergori, Alessandro Cozzi-Lepri, Giulia Matusali, et al.
Pageof 9